FDA Warning Letter to The Wilatta Group Inc. (2026-04-08) — Foreign Supplier Verification Program (FSVP)
Letter issued · posted to fda.gov .
Subject as published: Foreign Supplier Verification Program (FSVP)
TL;DR
Key takeaway: FDA issued a Warning Letter to The Wilatta Group Inc. on 2026-04-08 citing: Foreign Supplier Verification Program (FSVP). Full letter: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wilatta-group-inc-727025-04082026
Argus analysis
The Wilatta Group Inc. (MARCS-CMS 727025) received an FDA Warning Letter dated April 8, 2026 from the Office of Inspections and Investigations. The letter cites: Foreign Supplier Verification Program (FSVP). FDA posts Warning Letters to fda.gov after an internal review period; this one was made public on April 28, 2026.
FSVP letters cite 21 CFR Part 1, Subpart L, which requires food importers to verify that their foreign suppliers produce food meeting US safety standards. Common findings include no FSVP on file, an FSVP that fails to include a hazard analysis, or one not signed and dated by a qualified individual — omissions FDA treats as an importer-level compliance gap independent of the foreign facility's own record.
FDA Warning Letters typically specify a 15-working-day response window for the recipient to detail corrective actions. Compliance teams at peer companies in the same general compliance category commonly use a newly published letter as a prompt to re-check their own procedures against the same citation, and to watch fda.gov for a close-out letter confirming the cited firm's corrective action was accepted — or, absent one, for escalation to import alert, injunction, or product seizure.
Severity context
Low severity. Procedural or narrow scope; most peer companies resolve in the 15-business-day response window without structural change.
Regulatory background
FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER The Wilatta Group Inc. MARCS-CMS 727025 — April 08, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Email Product: Food & Beverages Recipient: Recipient Name Eugene Krofah Recipient Title Owner and General Manager The Wilatta Group Inc. 10310 Pond Spice Ter. Burke , VA 22015-3739 United States ekrofah@wilatta.com Issuing Office: Office of Inspections and Investigations United States WARNING LETTER RE: CMS# 727025 Dear Mr. Krofah, On March 10, 2026, through March 18, 2026, the Food and Drug Administration (FDA) conducted a Foreign Supplier Verification Program (FSVP) inspection of The Wilatta Group Inc located at 10310 Pond Spice Ter, Burke, VA 22015-3739. We also conducted inspections from September 18, 2022, through September 23, 2022, and September 17, 2019, through September 24, 2019. These inspections were conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1, subpart L. The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals. During the most recent inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the foods you import. Because of these significant violations, you are not in compliance with section 805 of the FD&C Act. At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations. We have not received your response to the Form FDA 483a issued on March 18, 2026. Your significant violations of the FSVP regulation are as follows: You did not develop, maintain, and follow an FSVP as required by section 805 of the FD&C Act and 21 CFR part 1.502(a). Specifically, you did not develop an FSVP for any of the foods you import, including each of the following foods: o Melon seeds, imported from (b)(4) , located in (b)(4) . o Condensed milk powder, imported from (b)(4) , located in (b)(4) . o Chocolate spread, imported from (b)(4) , located in (b)(4) . The above violations are not intended to be an all-inclusive list of violations of the FSVP requirements. It is your responsibility to ensure that you are in compliance with section 805 of the FD&C Act and the implementing regulation in 21 CFR part 1, subpart L. This letter notifies you of our concerns and provides you an opportunity to address them. If you do not adequately address this matter, we may take further action. F…
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- What is the regulatory background for a Warning Letter warning letter?
- FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- Has The Wilatta Group Inc. had FDA enforcement actions before?
- This is the only FDA Warning Letter Argus HQ has on file for The Wilatta Group Inc. as of 2026-04-28. Argus ingests new FDA enforcement records daily.
- What FDA violations was The Wilatta Group Inc. cited for?
- The FDA Warning Letter to The Wilatta Group Inc. (issuing office: Office of Inspections and Investigations) cites: Foreign Supplier Verification Program (FSVP). Classification: Warning Letter.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. $199/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Warning Letter to The Wilatta Group Inc. (2026-04-08) — Foreign Supplier Verification Program (FSVP). Digital Empire LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-the-wilatta-group-inc-2026-04-08-warning-letter
"FDA Warning Letter to The Wilatta Group Inc. (2026-04-08) — Foreign Supplier Verification Program (FSVP)." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-the-wilatta-group-inc-2026-04-08-warning-letter.
Argus HQ Research. "FDA Warning Letter to The Wilatta Group Inc. (2026-04-08) — Foreign Supplier Verification Program (FSVP)." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/fda/warning-letter/fda-wl-the-wilatta-group-inc-2026-04-08-warning-letter.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_the_wilatta_group_inc_2026_04_08_warning_letter_2026,
title = {FDA Warning Letter to The Wilatta Group Inc. (2026-04-08) — Foreign Supplier Verification Program (FSVP)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-the-wilatta-group-inc-2026-04-08-warning-letter},
note = {Accessed: July 13, 2026}
}